Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Jones, Steven P ^a   Greer, James J M ^a   Kakkar, Aman K ^a   Ware, P Derek ^a   Turnage, Richard H ^a   Hicks, Michael ^a   Van Haperen, Rien ^b   De Crom, Rini ^b   Kawashima, Seinosuke ^c   Yokoyama, Mitsuhiro ^c   Lefer, David J ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac dysfunction; Murine model; Myocardial infarction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG ANTAGONISM; ECHOCARDIOGRAPHY; ENOS GENE; ENZYME DEFICIENCY; GENE; GENE OVEREXPRESSION; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEMODYNAMICS; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REPERFUSION INJURY; STRAIN DIFFERENCE; TRANSGENIC MOUSE;

EID: 9144252563     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00129.2003     Document Type: Article

References (36)

1. Brunner F, Andrew P, Wolkart G, Zechner R, and Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104: 3097-3102,2001.
2. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, and Mayer B. Attenuation of myocardial ischemia-reperfusion injury in mice with myocyte overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57: 55-62, 2003.
3. Draper NJ and Shah AJ. Beneficial effects of a nitric oxide donor on recovery of contractile function following brief hypoxia in isolated rat heart. J Mol Cell Cardiol 29: 1195-1205, 1997.
4. Furchgott RF and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
5. Hasebe N, Shen YT, and Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation 88: 2862-2871, 1993.
6. Heger J, Godecke A, Flogel U, Merx MW, Molojavyi A, Kuhn-Velten WN, and Schrader U. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 90: 93-99, 2002.
7. Ignarro LJ, Buga GM, Wei LH, Bauer PM, Wu G, and del Soldato P. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 98: 4202-4208, 2001.
8. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowtiz PJ, and Gruetter CA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218: 739-749, 1981.
9. Ignarro LJ, Napoli C, and Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90: 21-28, 2002.
10. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, and Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519-14522, 1992.
11. Johnson G, Tsao PS, and Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19: 244-252, 1991.
12. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'heuil D, Huang PL, and Lefer DJ. Myocardial ischemia-reperfusion injury is exacerbated in the absence of endothelial cell nitric oxide synthase. Am J Physiol Heart Circ Physiol 276: H1567-H1573, 1999.
13. Jones SP, Greer JJM, van Haperen R, Duncker DJ, de Crom R, and Lefer DJ. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci USA 100: 4891-4896, 2003.
14. Jones SP, Trocha SD, and Lefer DJ. Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion. Arterioscler Thromb Vasc Biol 21: 2059-2064, 2001.
15. Kawashima S, Yamashita T, Ozaki M, Ohashi Y, Azumi H, Inoue N, Hirata K, Hayashi Y, Itoh H, and Yokoyama M. Endothelial NO synthase overexpression inhibits lesion formation in mouse model of vascular remodeling. Arterioscler Thromb Vasc Biol 21: 201-207, 2001.
16. Kelly RA, Balligand JL, and Smith TW. Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996.
17. Kubes P and Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655, 1991.
18. Kurose I, Wolf R, Grisham MB, and Granger DN. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74: 376-382, 1994.
19. Laumonnier Y, Nadaud S, Agrapart M, and Soubrier F. Characterization of an upstream enhancer region in the promoter of the human endothelial nitric oxide synthase gene. J Biol Chem 275: 40732-40741, 2000.
20. Lefer DJ, Nakanishi K, Johnston WE, and Vinten-Johansen J. Anti-neutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
21. Lorenz JN and Robbins J. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am J Physiol Heart Circ Physiol 272: H1137-H1146, 1997.
22. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorovo EG, Hyman AL, and Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′ -monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57: 946-955, 1981.
23. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC, McGee DS, and Johnston WE. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol Heart Circ Physiol 263: H1650-H1658, 1992.
24. ATP channels in rabbits. Am J Physiol Heart Circ Physiol 283: H1263-H1269, 2002.
25. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, and Yokoyama M. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest 102: 2061-2071, 1998.
26. Ozaki M, Kawashima S, Hirase T, Yamashita T, Namiki M, Inoue N, Hirata K, and Yokoyama M. Overexpression of endothelial nitric oxide synthase in endothelial cells is protective against ischemia-reperfusion injury in mouse skeletal muscle. Am J Pathol 160: 1335-1344, 2002.
27. Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, and Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest 110: 331-340, 2002.
28. Pabla R, Buda AJ, Flynn DM, Blesse SA, Shin AM, Curtis MJ, and Lefer DJ. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res 78: 65-72, 1996.
29. Pabla R, Buda AJ, Flynn DM, Salzberg DB, and Lefer DJ. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol Heart Circ Physiol 269: H1113-H1121, 1995.
30. Siegfried MR, Carey C, Ma XL, and Lefer AM. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol 263: H771-H777, 1992.
31. Van Haperen R, de Waard M, van Deel E, Mees B, Kutryk M, van Aken T, Hamming J, Grosveld F, Dunker DJ, and de Crom R. Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated nitric oxide synthase. J Biol Chem 277: 48803-48807, 2002.
32. Weyrich AS, Ma XL, and Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288, 1992.
33. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, and Bolli R. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279: H2360-H2371, 2000.
34. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Rikitake Y, Inoue N, Hirata K, Akita H, and Yokoyama M. Mechanisms of reduced NO/cGMP-mediated vasorelaxations in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension 36: 97-102, 2000.
35. Yamashita T, Kawashima S, Ohashi Y, Ozaki M, Ueyama T, Ishida T, Inoue N, Hirata K, Akita H, and Yokoyama M. Resistance to endotoxin shock in transgenic mice overexpressing endothelial nitric oxide synthase. Circulation 101: 931-937, 2000.
36. Zhao T, Xi L, Chelliah J, Levasseur MS, and Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine At receptors. Circulation 102: 902-908, 2001.